Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Active not recruiting 18Recruiting 17Completed 10Not yet recruiting 7Withdrawn 3Unknown 3Terminated 3Suspended 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Biliary Carcinoma 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × zimberelimab × Clear all
NCT06107114 2023-11-22

CZCNRHNSCC

Sun Yat-sen University

Phase 2 Unknown
52 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05540483 2022-09-16

RIGHT

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown
31 enrolled
Gastrointestinal

Biliary Carcinoma

NCT03972722 2019-06-05

CC

Guangzhou Gloria Biosciences Co., Ltd.

Phase 2 Unknown
89 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡